- Home
- INDO vs CODX Comparison
INDO vs CODX Comparison
Compare INDO & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDO
- CODX
- Stock Information
- Founded
- INDO 2018
- CODX 2013
- Country
- INDO Indonesia
- CODX United States
- Employees
- INDO N/A
- CODX N/A
- Industry
- INDO Oil & Gas Production
- CODX Medical/Dental Instruments
- Sector
- INDO Energy
- CODX Health Care
- Exchange
- INDO Nasdaq
- CODX Nasdaq
- Market Cap
- INDO 35.1M
- CODX 9.8M
- IPO Year
- INDO 2019
- CODX 2017
- Fundamental
- Price
- INDO $3.19
- CODX $0.28
- Analyst Decision
- INDO
- CODX Buy
- Analyst Count
- INDO 0
- CODX 2
- Target Price
- INDO N/A
- CODX $5.50
- AVG Volume (30 Days)
- INDO 8.5M
- CODX 381.9K
- Earning Date
- INDO 07-11-2025
- CODX 08-07-2025
- Dividend Yield
- INDO N/A
- CODX N/A
- EPS Growth
- INDO N/A
- CODX N/A
- EPS
- INDO N/A
- CODX N/A
- Revenue
- INDO $2,667,508.00
- CODX $3,497,583.00
- Revenue This Year
- INDO N/A
- CODX N/A
- Revenue Next Year
- INDO N/A
- CODX $42.11
- P/E Ratio
- INDO N/A
- CODX N/A
- Revenue Growth
- INDO N/A
- CODX N/A
- 52 Week Low
- INDO $2.06
- CODX $0.23
- 52 Week High
- INDO $7.95
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- INDO 48.40
- CODX 47.61
- Support Level
- INDO $2.92
- CODX $0.27
- Resistance Level
- INDO $3.30
- CODX $0.30
- Average True Range (ATR)
- INDO 0.84
- CODX 0.03
- MACD
- INDO -0.16
- CODX 0.00
- Stochastic Oscillator
- INDO 5.49
- CODX 54.00
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.